Clinical Trial Update: Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients

View source ↗

Summary

Clinical trial update noting ongoing recruitment for a study that longitudinally characterizes the microbial signature in systemic sclerosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Hôpital Européen Marseille | Conditions: Systemic Sclerosis | Status: RECRUITING